Figure 1‑1: Vascular Access Devices and Accessories Market Share Ranking by Segment, U.S., 2022 (1 of 3) |
Figure 1‑2: Vascular Access Devices and Accessories Market Share Ranking by Segment, U.S., 2022 (2 of 3) |
Figure 1‑3: Vascular Access Devices and Accessories Market Share Ranking by Segment, U.S., 2022 (3 of 3) |
Figure 1‑4: Companies Researched in This Report (1 of 2) |
Figure 1‑5: Companies Researched in This Report (2 of 2) |
Figure 1‑6: Factors Impacting the Vascular Access Devices and Accessories Market by Segment, U.S. (1 of 3) |
Figure 1‑7: Factors Impacting the Vascular Access Devices and Accessories Market by Segment, U.S. (2 of 3) |
Figure 1‑8: Factors Impacting the Vascular Access Devices and Accessories Market by Segment, U.S. (3 of 3) |
Figure 1‑9: Recent Events in the Vascular Access Devices and Accessories Market, U.S., 2019 – 2022 (1 of 2) |
Figure 1‑10: Recent Events in the Vascular Access Devices and Accessories Market, U.S., 2019 – 2022 (2 of 2) |
Figure 1‑11: Vascular Access Devices and Accessories Procedures Covered (1 of 4) |
Figure 1‑12: Vascular Access Devices and Accessories Procedures Covered (2 of 4) |
Figure 1‑13: Vascular Access Devices and Accessories Procedures Covered (3 of 4) |
Figure 1‑14: Vascular Access Devices and Accessories Procedures Covered (4 of 4) |
Figure 1‑15: Procedure Codes Investigated |
Figure 1‑16: Vascular Access Devices and Accessories Markets Covered (1 of 8) |
Figure 1‑17: Vascular Access Devices and Accessories Markets Covered (2 of 8) |
Figure 1‑18: Vascular Access Devices and Accessories Markets Covered (3 of 8) |
Figure 1‑19: Vascular Access Devices and Accessories Markets Covered (4 of 8) |
Figure 1‑20: Vascular Access Devices and Accessories Markets Covered (5 of 8) |
Figure 1‑21: Vascular Access Devices and Accessories Markets Covered (6 of 8) |
Figure 1‑22: Vascular Access Devices and Accessories Markets Covered (7 of 8) |
Figure 1‑23: Vascular Access Devices and Accessories Markets Covered (8 of 8) |
Figure 1‑24: Key Report Updates (1 of 2) |
Figure 1‑25: Key Report Updates (2 of 2) |
Figure 1‑26: Version History |
Figure 2‑1: Vascular Access Devices and Accessories Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑2: Vascular Access Devices and Accessories Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 2‑3: Vascular Access Devices and Accessories Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑4: Vascular Access Devices and Accessories Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 2‑5: Vascular Access Devices and Accessories Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
Figure 2‑6: Vascular Access Devices and Accessories Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
Figure 4‑1: Implantable Ports by Company |
Figure 4‑2: Port Needles by Company (1 of 2) |
Figure 4‑3: Port Needles by Company (2 of 2) |
Figure 4‑4: Central Venous Catheters by Company |
Figure 4‑5: Peripherally Inserted Central Catheters by Company |
Figure 4‑6: Peripheral Intravenous Catheters by Company |
Figure 4‑7: Midlines by Company |
Figure 4‑8: Extended Dwell Catheter by Company |
Figure 4‑9: Dialysis Catheters by Company (1 of 2) |
Figure 4‑10: Dialysis Catheters by Company (2 of 2) |
Figure 4‑11: Ultrasound Vascular Access Devices and Accessories by Company |
Figure 4‑12: Vein Visualization by Company |
Figure 4‑13: Tip-Placement System and Accessories by Company |
Figure 4‑14: Catheter Securement by Company (1 of 2) |
Figure 4‑15: Catheter Securement by Company (2 of 2) |
Figure 4‑16: Antibacterial Catheter Patch by Company |
Figure 4‑17: Catheter Cap by Company |
Figure 4‑18: Syringes and Needles by Company (1 of 2) |
Figure 4‑19: Syringes and Needles by Company (2 of 2) |
Figure 4‑20: Class 2 Device Recall PowerPort duo M.R.I. Implantable Port |
Figure 4‑21: Class 2 Device Recall Smart Port CT |
Figure 4‑22: Class 2 Device Recall PORTACATH II POWER P.A.C. Low Profile" System |
Figure 4‑23: Class 2 Device Recall BARD Access Systems PowerPort ClearVUE Slim Implantable Port |
Figure 4‑24: Class 2 Device Recall Vaccess CT PowerInjectable Implantable Port |
Figure 4‑25: Class 2 Device Recall XPort isp M.R.I. Implantable Port |
Figure 4‑26: Class 2 Device Recall Power Port Implantable Port |
Figure 4‑27: Class 2 Device Recall PowerPort M.R.I. Implantable Port |
Figure 4‑28: Class 2 Device Recall BardPort Titanium Implantable Port |
Figure 4‑29: Class 2 Device Recall BardPort M.R.I. Hard Base Implantable Port |
Figure 4‑30: Class 2 Device Recall Powerport Cleavue Slim Implantable Port |
Figure 4‑31: Class 2 Device Recall Bard Access Systems PowerPort isp M.R.I. Implantable Port |
Figure 4‑32: Class 2 Device Recall BioFlo Port with ENDEXO and PASV Technology |
Figure 4‑33: Class 2 Device Recall Port Access Kit |
Figure 4‑34: Class 2 Device Recall SafeStep Huber Needle Set |
Figure 4‑35: Class 2 Device Recall PowerLoc MAX Power |
Figure 4‑36: Class 2 Device Recall GRIPPER Needles |
Figure 4‑37: Class 1 Device Recall Arrow Pressure Injectable Arrowgard Blue Plus ThreeLumen CVC Kit |
Figure 4‑38: Class 2 Device Recall Arrow ThreeLumen CVC |
Figure 4‑39: Class 2 Device Recall Arrow Teleflex |
Figure 4‑40: Class 2 Device Recall Groshong CV Catheter |
Figure 4‑41: Class 2 Device Recall Centurion |
Figure 4‑42: Class 2 Device Recall Arrow AGB MultiLumen CVC Kit |
Figure 4‑43: Class 2 Device Recall ARROWgard Blue Plus |
Figure 4‑44: Class 2 Device Recall ARROWgard Blue Plus MultiLumen CVC Kit |
Figure 4‑45: Class 2 Device Recall PICC KIT |
Figure 4‑46: Class 2 Device Recall Various PICC Line, Central Line Packs |
Figure 4‑47: Class 2 Device Recall Navilyst |
Figure 4‑48: Class 2 Device Recall 5Fr PowerPICC Catheter SingleLumen with 70cm Guidewire |
Figure 4‑49: Class 2 Device Recall BioFlo and Xcela |
Figure 4‑50: Class 2 Device Recall Arrow PICC |
Figure 4‑51: Class 2 Device Recall Arrow Pressure Injectable PICC |
Figure 4‑52: Class 2 Device Recall Navilyst Medical BioFlo PICC with ENDEXO and PASV |
Figure 4‑53: Class 2 Device Recall BD Nexiva Closed IV Catheter System |
Figure 4‑54: Class 2 Device Recall BD Nexiva 20 GA 1.00 (1.1 x 25mm) Dual Port |
Figure 4‑55: Class 2 Device Recall DELTAVEN Safety I.V. Catheter in Pur with closed system |
Figure 4‑56: Class 2 Device Recall B. Braun Introcan Safety IV Catheters |
Figure 4‑57: Class 2 Device Recall BD Nexiva Closed IV Catheter System Dual Port |
Figure 4‑58: Class 2 Device Recall BD Nexiva Closed IV Catheter System |
Figure 4‑59: Class 2 Device Recall Jelco(R) ViaValve(TM) Safety Intravenous (I.V.) Catheters |
Figure 4‑60: Class 2 Device Recall ARROW Pressure Injectable Arrowgard Blue Advance Midline Kit |
Figure 4‑61: Class 2 Device Recall PowerMidline Catheter |
Figure 4‑62: Class 2 Device Recall BioFlo Midline |
Figure 4‑63: Class 2 Device Recall PowerGlide ST Midline Catheter Maximal Barrier |
Figure 4‑64: Class 2 Device Recall Arrowgard Blue Advance Midline |
Figure 4‑65: Class 2 Device Recall Peripherally Inserted Midline Catheter Kit with Placement Wire |
Figure 4‑66: Class 3 Device Recall POWERWAND XL 4Fr 10cm Maximum Barrier Kit |
Figure 4‑67: Class 2 Device Recall Arrow Endurance Catheter System |
Figure 4‑68: Class 1 Device Recall Mahurkar |
Figure 4‑69: Class 1 Device Recall Hemodialysis Catheter |
Figure 4‑70: Class 2 Device Recall Hemodialysis Implanted Catheter |
Figure 4‑71: Class 2 Device Recall PowerTrialysis ShortTerm Alphacurve Dialysis Catheter |
Figure 4‑72: Class 2 Device Recall EQUISTREAM LongTerm Hemodialysis Catheter |
Figure 4‑73: Class 2 Device Recall GLIDEPATH LongTerm Hemodialysis Catheter |
Figure 4‑74: Class 2 Device Recall 14F SLX Double Lumen Full Tray |
Figure 4‑75: Class 2 Device Recall MAHURKAR" and Argyle" Acute Hemodialysis Catheters |
Figure 4‑76: Class 2 Device Recall 14F SLX Double Lumen Full Tray |
Figure 4‑77: Class 2 Device Recall Vivid |
Figure 4‑78: Class 2 Device Recall ACUSON Juniper Diagnostic Ultrasound System |
Figure 4‑79: Class 2 Device Recall Vscan Extend System, Imaging, Pulsed Echo, Ultrasonic |
Figure 4‑80: Class 2 Device Recall AC/DC POWER SUPPLY for 7400 |
Figure 4‑81: Class 2 Device Recall SiteRite 8 Ultrasound Systems |
Figure 4‑82: Class 2 Device Recall VPS Rhythm ECG Accessory Pack |
Figure 4‑83: Class 2 Device Recall Busse I.V. START KIT |
Figure 4‑84: Class 2 Device Recall MERSILK and PERMAHAND, Braided Silk and Virgin Silk NonAbsorbable Suture |
Figure 4‑85: Class 2 Device Recall Coated VICRYL (Polyglactin 910) Suture |
Figure 4‑86: Class 2 Device Recall ETHIBOND EXCEL ETHIBOND Polyester Suture |
Figure 4‑87: Class 2 Device Recall 3M Durapore Advanced Surgical Tape |
Figure 4‑88: Class 2 Device Recall HEB InControl Insulin Syringe |
Figure 4‑89: Class 1 Device Recall Monoject 0.9 Sodium Chloride Flush Syringe |
Figure 4‑90: Class 1 Device Recall JELCO HYPODERMIC NEEDLEPRO FIXED NEEDLE INSULIN SYRINGE |
Figure 4‑91: Class 2 Device Recall Covidien |
Figure 4‑92: Class 2 Device Recall BD PrecisionGlide Needle 30G x 1/2 |
Figure 4‑93: Class 2 Device Recall BD UltraFine Pen Needles 32G x 4mm |
Figure 4‑94: Class 2 Device Recall Monoject Standard Hypodermic Needle |
Figure 4‑95: Class 2 Device Recall BD SafetyGlideTM 3ml 25G x 1 |
Figure 4‑96: Class 2 Device Recall Monoject Hypodermic Safety Needle |
Figure 4‑97: Class 2 Device Recall GRIPPER Needles |
Figure 4‑98: Class 2 Device Recall 3mL SafetyLok Syringe |
Figure 4‑99: Class 2 Device Recall 3mL LuerLok Syringe |
Figure 4‑100: Safety of Extending the Routine Flushing of Implanted Port Devices from 4 Weeks to 12 |
Figure 4‑101: Interest of Virtual Reality to Reduce Patient Anxiety During the Placement of a Percutaneous Implantable Port Catheter (RV-CIP) |
Figure 4‑102: A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports |
Figure 4‑103: Comparison Between Internal Jugular Vein Versus Axillary Vein for Implantable Ports |
Figure 4‑104: Maintaining Patency in Implanted Port Catheters |
Figure 4‑105: Ultrasound Guided Port-A-Cath Insertion in Cancer Patients |
Figure 4‑106: Study on Indications of "Bard" PowerPort Isp Implantable Port (BPIP) |
Figure 4‑107: Wire-in-needle vs. Traditional Technique for Ultrasound-Guided Central Venous Catheter Placement |
Figure 4‑108: Central Venous Catheter-Related Complications in Patients Under Anticancer Treatment (KTcCHO) |
Figure 4‑109: Infection Related to Short-Term Central Venous Catheters |
Figure 4‑110: Point of Care Ultrasonography Versus Standard Blind Technique for Central Venous Catheter Insertion in Emergency Hospital |
Figure 4‑111: Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients |
Figure 4‑112: Novel Strategy to Encourage Early Removal of Central Venous Catheters |
Figure 4‑113: Novel Strategy to Encourage Early Removal of Central Venous Catheters |
Figure 4‑114: Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit (PICINI) |
Figure 4‑115: Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics (ComPLET) |
Figure 4‑116: Comparing Arrow PICC Catheters w/ Arrowga+rd Blue Advanced Protection Performance and Safety to Unprotected PICC's |
Figure 4‑117: Prospective Observational Study of the Power PICC Family of Devices and Accessories |
Figure 4‑118: Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates |
Figure 4‑119: Major Complications Related to PICC and Midline Insertion (PICC/MIDLINE) |
Figure 4‑120: Safety and Effectiveness of CATHTONG™ II PICC |
Figure 4‑121: Ultrasound-Guided Peripheral Intravenous Catheter Insertion Technique (PIVC) |
Figure 4‑122: Comparison of Two Peripheral Inserted Intravenous Catheters |
Figure 4‑123: Impact of PIVC Length and Gauge on Catheter Indwell Time |
Figure 4‑124: Impact of a Multimodal Intervention on Peripheral Venous Catheterization of Cancer Patients (MultiCat) |
Figure 4‑125: Peripheral Intravenous Catheter Securement with Tissue Adhesive |
Figure 4‑126: Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit (PICINI) |
Figure 4‑127: Midline Catheter and Its Impact on Central Lines Removal in ICU (MIDREA) |
Figure 4‑128: Patient Perspective Midline Catheter in the Emergency Department |
Figure 4‑129: Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic Polyurethane |
Figure 4‑130: Safety and Efficacy of Midline and PICC (MidLine_PICC) |
Figure 4‑131: Midlines and Thrombophlebitis |
Figure 4‑132: Midline Catheter and Its Impact on Central Lines Removal in ICU (MIDREA) |
Figure 4‑133: Upper Limb Thrombosis Associated With Midline Catheter |
Figure 4‑134: The Clinical Efficacy of Midline Catheters |
Figure 4‑135: Occurrence of Emerging Infections After Placement of a Peritoneal Dialysis CatHeter (SINEPHILE) |
Figure 4‑136: Tunneled Dialysis Catheters Versus Non-Tunneled Dialysis Catheters as First-Line for Renal Replacement Therapy in the ICU (BACKDOOR) |
Figure 4‑137: Straight Versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients |
Figure 4‑138: A Percutaneous Ultrasound Device with Needle Guide for Vascular Access |
Figure 4‑139: Ultrasound Guided Peripheral Catheterization Increases First-Attempt Success Rate (SPECTRA) |
Figure 4‑140: Ultrasound-Guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses |
Figure 4‑141: Efficacy of an Infrared Visualization Technique for the Identification of the Peripheral Venous Access Site in Patients with Cystic Fibrosis Aged 12 Years and Older (MUCOVEINE) |
Figure 4‑142: Infra Red Vein Visualization: Efficacy vs. Standard Technique |
Figure 4‑143: Can Veinlite Reduce Complications of Peripheral Intravenous Catheter Placement in Children |
Figure 4‑144: Innovative Central Line Securement Device in the Pediatric Population |
Figure 4‑145: A New Securement Method for External Tunneled Central Venous Access Devices (CVAD) |
Figure 4‑146: Comparison of Sterile Gauze and Semi-Permeable Film Dressing for Hemodialysis Central Venous Catheter |
Figure 4‑147: A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices |
Figure 4‑148: Prospective Healthy Volunteer Study of the Securis™ Stabilization Device |
Figure 4‑149: Peripheral Intravenous Catheter Securement with Tissue Adhesive |
Figure 5‑1: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 3) |
Figure 5‑2: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 3) |
Figure 5‑3: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 (US$M) (3 of 3) |
Figure 5‑4: Leading Competitors, Vascular Access Devices and Accessories Market, U.S., 2022 (1 of 2) |
Figure 5‑5: Leading Competitors, Vascular Access Devices and Accessories Market, U.S., 2022 (2 of 2) |
Figure 5‑6: SWOT Analysis, 3M |
Figure 5‑7: SWOT Analysis, AccuVein |
Figure 5‑8: SWOT Analysis, AngioDynamics |
Figure 5‑9: SWOT Analysis, B. Braun |
Figure 5‑10: SWOT Analysis, Becton Dickinson (1 of 2) |
Figure 5‑11: SWOT Analysis, Becton Dickinson (2 of 2) |
Figure 5‑12: SWOT Analysis, Cardinal Health |
Figure 5‑13: SWOT Analysis, FUJIFILM SonoSite |
Figure 5‑14: SWOT Analysis, GE Healthcare |
Figure 5‑15: SWOT Analysis, ICU Medical |
Figure 5‑16: SWOT Analysis, Johnson & Johnson |
Figure 5‑17: SWOT Analysis, Medcomp |
Figure 5‑18: SWOT Analysis, Novo Nordisk |
Figure 5‑19: SWOT Analysis, Teleflex Medical |
Figure 6‑1: Procedure Codes Investigated, U.S., 2022 |
Figure 6‑2: Vascular Access Procedure Numbers, U.S., 2019 – 2029 (1 of 2) |
Figure 6‑3: Vascular Access Procedure Numbers, U.S., 2019 – 2029 (2 of 2) |
Figure 6‑4: Implantable Port Insertion Procedures by Material, U.S., 2019 – 2029 |
Figure 6‑5: Implantable Port Insertion Procedures by Valve Type, U.S., 2019 – 2029 |
Figure 6‑6: Implantable Port Insertion Procedures by Power-Injectability, U.S., 2019 – 2029 |
Figure 6‑7: Implantable Port Insertion Procedures by Location, U.S., 2019 – 2029 |
Figure 6‑8: Implantable Port Insertion Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑9: Implantable Port Insertion Procedures by Patient Age Group, U.S., 2019 – 2029 |
Figure 6‑10: Implantable Port Insertion Procedures by Operator, U.S., 2019 – 2029 |
Figure 6‑11: Port Needle Insertion Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑12: Central Venous Catheter Insertion Procedures by Device Type, U.S., 2019 – 2029 |
Figure 6‑13: Central Venous Catheter Insertion Procedures by Insertion Site U.S., 2019 – 2029 |
Figure 6‑14: CVC Insertion Procedures by Imaging Technique, U.S., 2019 – 2029 |
Figure 6‑15: Central Venous Catheter Insertion Procedures by Patient Type, U.S., 2019 – 2029 |
Figure 6‑16: Peripherally Inserted Central Catheter Insertion Procedures by Power-Injectability, U.S., 2019 – 2029 |
Figure 6‑17: Peripherally Inserted Central Catheter Insertion Procedures by Patient Age Group, U.S., 2019 – 2029 |
Figure 6‑18: Peripherally Inserted Central Catheter Insertion Procedures by Operator, U.S., 2019 – 2029 |
Figure 6‑19: Peripherally Inserted Central Catheter Insertion Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑20: Mean Peripheral Intravenous Catheters Used Per Procedure, U.S., 2019 – 2029 |
Figure 6‑21: Peripheral Intravenous Catheter Insertion Procedures by Setting, U.S., 2019 – 2029 |
Figure 6‑22: Peripheral Intravenous Catheter Insertion Procedures by Device Type, U.S., 2019 – 2029 |
Figure 6‑23: Peripheral Intravenous Catheter Insertion Procedures by Insertion Site, U.S., 2019 – 2029 |
Figure 6‑24: Peripheral Intravenous Catheter Insertion Procedures by Visualization Method, U.S., 2019 – 2029 |
Figure 6‑25: Midline Placement Procedures by Device Type, U.S., 2019 – 2029 |
Figure 6‑26: Midline Placement Procedures by Power-Injectability, U.S., 2019 – 2029 |
Figure 6‑27: Extended Dwell Placement Procedures, U.S., 2019 – 2029 |
Figure 6‑28: Dialysis Catheter Placement Procedures by Device Type, U.S., 2019 – 2029 |
Figure 6‑29: Vascular Access Catheters Placed Using Ultrasound Guidance, U.S., 2019 – 2029 |
Figure 6‑30: Vascular Access Catheters Placed Using Ultrasound Guidance by Operator, U.S., 2019 – 2029 |
Figure 6‑31: PIVCs Placed Using Vein Visualization, U.S., 2019 – 2029 |
Figure 6‑32: Vascular Access Catheters Placed Using Tip-Placement Devices by Catheter Type, U.S., 2019 – 2029 |
Figure 6‑33: Vascular Access Catheters Placed Using Tip-Placement Device by Operator, U.S., 2019 – 2029 |
Figure 7‑1: Implantable Port Market by Material, U.S., 2019 – 2029 (US$M) |
Figure 7‑2: Implantable Port Market by Valve Type, U.S., 2019 – 2029 (US$M) |
Figure 7‑3: Implantable Port Market by Device Properties, U.S., 2019 – 2029 (US$M) |
Figure 7‑4: Total Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑5: Total Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑6: Full Plastic Implantable Port Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
Figure 7‑7: Single-Lumen Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑8: Double-Lumen Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑9: Full Plastic Implantable Port Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
Figure 7‑10: Power-Injectable Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑11: Non-Power-Injectable Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑12: Total Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑13: Full Titanium Implantable Port Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
Figure 7‑14: Single-Lumen Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑15: Double-Lumen Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑16: Full Titanium Implantable Port Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
Figure 7‑17: Power-Injectable Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑18: Non-Power-Injectable Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑19: Total Hybrid Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑20: Hybrid Implantable Port Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
Figure 7‑21: Single-Lumen Hybrid Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑22: Double-Lumen Hybrid Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑23: Hybrid Implantable Port Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
Figure 7‑24: Power-Injectable Hybrid Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑25: Non-Power-Injectable Hybrid Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑26: Valved Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑27: Non-Valved Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑28: Antithrombogenic Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑29: Conventional Implantable Port Market, U.S., 2019 – 2029 |
Figure 7‑30: Leading Competitors, Implantable Port Market, U.S., 2022 |
Figure 8‑1: Port Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 8‑2: Total Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑3: Acute Care Port Needle Market by Device Type, U.S., 2019 – 2029 |
Figure 8‑4: Acute Care Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑5: Acute Care Conventional Port Needle Market by Y-Site, U.S., 2019 – 2029 |
Figure 8‑6: Acute Care Conventional Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑7: Acute Care Conventional Port Needle With Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑8: Acute Care Conventional Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑9: Acute Care Safety Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑10: Acute Care Safety Port Needle Market by Power-Injectability, U.S., 2019 – 2029 |
Figure 8‑11: Acute Care Safety Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑12: Acute Care Safety Non-Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑13: Acute Care Safety Port Needle Market by Y-Site, U.S., 2019 – 2029 |
Figure 8‑14: Acute Care Safety Port Needle With Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑15: Acute Care Safety Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑16: Acute Care Safety Port Needle Market by Needleless Connector, U.S., 2019 – 2029 |
Figure 8‑17: Acute Care Safety Port Needle With Needleless Connector Market, U.S., 2019 – 2029 |
Figure 8‑18: Acute Care Safety Port Needle Without Needleless Connector Market, U.S., 2019 – 2029 |
Figure 8‑19: Alternate Care Port Needle Market by Device Type, U.S., 2019 – 2029 |
Figure 8‑20: Alternate Care Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑21: Alternate Care Conventional Port Needle Market by Y-Site, U.S., 2019 – 2029 |
Figure 8‑22: Alternate Care Conventional Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑23: Alternate Care Conventional Port Needle With Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑24: Alternate Care Conventional Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑25: Alternate Care Safety Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑26: Alternate Care Safety Port Needle Market by Power-Injectability, U.S., 2019 – 2029 |
Figure 8‑27: Alternate Care Safety Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑28: Alternate Care Safety Non-Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
Figure 8‑29: Alternate Care Safety Port Needle Market by Y-Site, U.S., 2019 – 2029 |
Figure 8‑30: Alternate Care Safety Port Needle With Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑31: Alternate Care Safety Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
Figure 8‑32: Alternate Care Safety Port Needle Market by Needleless Connector, U.S., 2019 – 2029 |
Figure 8‑33: Alternate Care Safety Port Needle With Needleless Connector Market, U.S., 2019 – 2029 |
Figure 8‑34: Alternate Care Safety Port Needle Without Needleless Connector Market, U.S., 2019 – 2029 |
Figure 8‑35: Leading Competitors, Port Needle Market, U.S., 2022 |
Figure 9‑1: Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 9‑2: Total Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑3: Acute Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 9‑4: Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑5: Conventional Acute Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 |
Figure 9‑6: Conventional Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑7: Single-Lumen Conventional Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑8: Multi-Lumen Conventional Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑9: Antimicrobial Acute Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 |
Figure 9‑10: Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑11: Impregnated Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑12: Coated Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑13: Antimicrobial Acute Central Venous Catheter Market by Lumen Count, U.S., 2019 – 2029 |
Figure 9‑14: Antimicrobial Acute Central Venous Catheter Market by Lumen Count, U.S., 2019 – 2029 |
Figure 9‑15: Single-Lumen Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑16: Multi-Lumen Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑17: Acute Central Venous Catheter Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
Figure 9‑18: Total Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑19: Power-Injectable Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑20: Non-Power-Injectable Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑21: Total Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑22: Chronic Central Venous Catheter Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
Figure 9‑23: Power-Injectable Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑24: Non-Power-Injectable Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑25: Chronic Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 9‑26: Advanced Materials Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑27: Conventional Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
Figure 9‑28: Leading Competitors, Central Venous Catheter Market, U.S., 2022 |
Figure 10‑1: Peripherally Inserted Central Catheter Market by Tip-Placement Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑2: Peripherally Inserted Central Catheter Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 10‑3: Peripherally Inserted Central Catheter Market by Valve Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑4: Peripherally Inserted Central Catheter Market by Kit Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑5: Total Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑6: Tip-Placement Peripherally Inserted Central Catheter Kit Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
Figure 10‑7: Tip-Placement Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
Figure 10‑8: Single-Lumen Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑9: Double-Lumen Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑10: Triple-Lumen Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑11: Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑12: Tip-Placement Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
Figure 10‑13: Non-Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑14: Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑15: Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑16: Antimicrobial Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑17: Conventional Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑18: Basic Peripherally Inserted Central Catheter Kit Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
Figure 10‑19: Basic Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
Figure 10‑20: Single-Lumen Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑21: Double-Lumen Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑22: Triple-Lumen Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑23: Basic Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑24: Basic Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
Figure 10‑25: Non-Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑26: Power-Injectable Basic Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑27: Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑28: Antimicrobial Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑29: Antithrombogenic Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑30: Conventional Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑31: Hospital-Based Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑32: Non-Hospital-Based Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑33: Valved Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑34: Non-Valved Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
Figure 10‑35: Long Guidewire Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
Figure 10‑36: Standard Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
Figure 10‑37: Peripherally Inserted Central Catheter Units Sold by Material, U.S., 2019 – 2029 |
Figure 10‑38: Peripherally Inserted Central Catheter Units Sold by Material and Lumen, U.S., 2022 |
Figure 10‑39: Peripherally Inserted Central Catheter Units Sold by Age and Material, U.S., 2022 |
Figure 10‑40: Leading Competitors, Peripherally Inserted Central Catheter Market, U.S., 2022 |
Figure 11‑1: Peripheral Intravenous Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 11‑2: Peripheral Intravenous Catheter Market by Setting, U.S., 2019 – 2029 (US$M) |
Figure 11‑3: Total Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑4: Conventional Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑5: Safety Peripheral Intravenous Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 11‑6: Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑7: Blood Control Safety Peripheral Intravenous Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 11‑8: Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑9: Integrated Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑10: Non-Integrated Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑11: Non-Blood Control Safety Peripheral Intravenous Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 11‑12: Non-Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑13: Non-Blood Control Active Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑14: Non-Blood Control Passive Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑15: Acute Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑16: Alternate Care Peripheral Intravenous Catheter Market by Setting, U.S., 2019 – 2029 (US$M) |
Figure 11‑17: Alternate Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑18: Home Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑19: Outpatient and Nursing Home Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
Figure 11‑20: Peripheral Intravenous Catheter Units Sold by Length, U.S., 2019 – 2029 |
Figure 11‑21: Peripheral Intravenous Catheter Units Sold by Insertion Site, U.S., 2019 – 2029 |
Figure 11‑22: Peripheral Intravenous Catheter Units Sold by Insertion Technique, U.S., 2019 – 2029 |
Figure 11‑23: Leading Competitors, Peripheral Intravenous Catheter Market, U.S., 2019 |
Figure 12‑1: Midline Market by Insertion Method, U.S., 2019 – 2029 (US$M) |
Figure 12‑2: Midline Market, U.S., 2019 – 2029 |
Figure 12‑3: AST Midline Market, U.S., 2019 – 2029 |
Figure 12‑4: MST Midline Market by Power Injectability, U.S., 2019 – 2029 |
Figure 12‑5: MST Midline Market, U.S., 2019 – 2029 |
Figure 12‑6: MST Midline Market by Power Injectability, U.S., 2019 – 2029 |
Figure 12‑7: Total Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
Figure 12‑8: Long Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
Figure 12‑9: Short Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
Figure 12‑10: Non-Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
Figure 12‑11: Leading Competitors, Midline Market, U.S., 2022 |
Figure 13‑1: Extended Dwell Catheter Market, U.S., 2019 – 2029 |
Figure 13‑2: Leading Competitors, Extended Dwell Catheter Market, U.S., 2022 |
Figure 14‑1: Dialysis Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 14‑2: Dialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑3: Hemodialysis Catheter Market by Dwell Time, U.S., 2019 – 2029 (US$M) |
Figure 14‑4: Total Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑5: Long-Term Hemodialysis Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 14‑6: Total Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑7: Conventional Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑8: Advanced Material Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑9: Long-Term Hemodialysis Catheter Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 14‑10: In Center Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑11: Home Care Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑12: Short-Term Hemodialysis Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 14‑13: Total Short-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑14: Power-Injectable Short-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑15: Non-Power-Injectable Short-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑16: Peritoneal Dialysis Catheter Market, U.S., 2019 – 2029 |
Figure 14‑17: Leading Competitors, Dialysis Catheter Market, U.S., 2022 |
Figure 15‑1: Ultrasound Vascular Access Device and Accessory Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 15‑2: Cart-Based Ultrasound System Specialized for Vascular Access Market, U.S., 2019 – 2029 |
Figure 15‑3: Hand-Carried and Portable Ultrasound System Specialized for Vascular Access Market, U.S., 2019 – 2029 |
Figure 15‑4: Leading Competitors, Ultrasound Vascular Access Device and Accessory Market, U.S., 2022 |
Figure 16‑1: Vein Visualization Technology Market, U.S., 2019 – 2029 |
Figure 16‑2: Leading Competitors, Vein Visualization Technology Market, U.S., 2022 |
Figure 17‑1: Tip-Placement System and Accessory Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 17‑2: Tip-Placement System Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 17‑3: Total Tip-Placement System Market, U.S., 2019 – 2029 |
Figure 17‑4: Standalone Tip-Placement System Market, U.S., 2019 – 2029 |
Figure 17‑5: Integrated Tip-Placement System Market, U.S., 2019 – 2029 |
Figure 17‑6: Disposable Tip-Placement Accessory Market, U.S., 2019 – 2029 |
Figure 17‑7: Leading Competitors, Tip-Placement System and Accessory Market, U.S., 2022 |
Figure 18‑1: Catheter Securement Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 18‑2: Catheter Securement Market, U.S., 2019 – 2029 |
Figure 18‑3: Tape and Dressing Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 18‑4: Total Tape and Dressing Market, U.S., 2019 – 2029 |
Figure 18‑5: Antimicrobial Tape and Dressing Market, U.S., 2019 – 2029 |
Figure 18‑6: Standard Tape and Dressing Market, U.S., 2019 – 2029 |
Figure 18‑7: Suture Market, U.S., 2019 – 2029 |
Figure 18‑8: Manufactured Catheter Securement Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 18‑9: Total Manufactured Catheter Securement Device Market, U.S., 2019 – 2029 |
Figure 18‑10: Mechanical Manufactured Catheter Securement Device Market, U.S., 2019 – 2029 |
Figure 18‑11: Non-Mechanical Manufactured Catheter Securement Device Market, U.S., 2019 – 2029 |
Figure 18‑12: Manufactured Catheter Securement Device Units Sold by Catheter Type, U.S., 2019 – 2029 |
Figure 18‑13: Leading Competitors, Catheter Securement Market, U.S., 2022 |
Figure 19‑1: Antibacterial Catheter Patch Market, U.S., 2019 – 2029 |
Figure 19‑2: Leading Competitors, Antibacterial Catheter Patch Market, U.S., 2022 |
Figure 20‑1: Catheter Cap Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 20‑2: Catheter Cap Market, U.S., 2019 – 2029 |
Figure 20‑3: Standard Catheter Cap Market, U.S., 2019 – 2029 |
Figure 20‑4: Dialysis Catheter Cap Market, U.S., 2019 – 2029 |
Figure 20‑5: Leading Competitors, Catheter Cap Market, U.S., 2022 |
Figure 21‑1: Syringe and Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 21‑2: Syringe Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 21‑3: Total Syringe Market, U.S., 2019 – 2029 |
Figure 21‑4: Conventional Syringe Market, U.S., 2019 – 2029 |
Figure 21‑5: Sliding Sleeve Safety Syringe Market, U.S., 2019 – 2029 |
Figure 21‑6: Retractable Safety Syringe Market, U.S., 2019 – 2029 |
Figure 21‑7: Hinged Safety Syringe Market, U.S., 2019 – 2029 |
Figure 21‑8: Insulin Syringe Market by Usage, U.S., 2019 – 2029 (US$M) |
Figure 21‑9: Total Insulin Syringe Market, U.S., 2019 – 2029 |
Figure 21‑10: Personal Insulin Syringe Market, U.S., 2019 – 2029 |
Figure 21‑11: Professional Insulin Syringe Market, U.S., 2019 – 2029 |
Figure 21‑12: Insulin Syringe Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 21‑13: Total Insulin Syringe Market, U.S., 2019 – 2029 |
Figure 21‑14: Safety Insulin Syringe Market, U.S., 2019 – 2029 |
Figure 21‑15: Non-Safety Insulin Syringe Market, U.S., 2019 – 2029 |
Figure 21‑16: Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 21‑17: Total Needle Market, U.S., 2019 – 2029 |
Figure 21‑18: Conventional Needle Market, U.S., 2019 – 2029 |
Figure 21‑19: Shielding Safety Needle Market, U.S., 2019 – 2029 |
Figure 21‑20: Pivoting Needle Market, U.S., 2019 – 2029 |
Figure 21‑21: Blunt Fill Needle Market, U.S., 2019 – 2029 |
Figure 21‑22: Insulin Pen Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 21‑23: Total Insulin Pen Needle Market, U.S., 2019 – 2029 |
Figure 21‑24: Safety Insulin Pen Needle Market, U.S., 2019 – 2029 |
Figure 21‑25: Non-Safety Insulin Pen Needle Market, U.S., 2019 – 2029 |
Figure 21‑26: Leading Competitors, Syringe and Needle Market, U.S., 2022 |
Figure 22‑1: Multi-Purpose Hand-Carried and Portable Ultrasound System Market, U.S., 2019 – 2029 |
Figure 22‑2: Leading Competitors, Multi-Purpose Hand-Carried and Portable Ultrasound Market, U.S., 2022 |